Mind Medicine (MindMed) (NASDAQ:MNMD) vs. Exactus (OTCMKTS:EXDI) Financial Survey

Exactus (OTCMKTS:EXDIGet Rating) and Mind Medicine (MindMed) (NASDAQ:MNMDGet Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and profitability.


This table compares Exactus and Mind Medicine (MindMed)’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Exactus N/A -3,272.69% -185.29%
Mind Medicine (MindMed) N/A -55.27% -51.10%

Institutional and Insider Ownership

0.1% of Exactus shares are owned by institutional investors. Comparatively, 10.8% of Mind Medicine (MindMed) shares are owned by institutional investors. 65.0% of Exactus shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Exactus and Mind Medicine (MindMed)’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Exactus $2.07 million 122.96 -$9.46 million N/A N/A
Mind Medicine (MindMed) N/A N/A -$93.04 million -0.23 -4.39

Exactus has higher revenue and earnings than Mind Medicine (MindMed).

Analyst Ratings

This is a breakdown of recent recommendations for Exactus and Mind Medicine (MindMed), as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exactus 0 0 0 0 N/A
Mind Medicine (MindMed) 0 0 2 0 3.00

Mind Medicine (MindMed) has a consensus target price of 8.00, indicating a potential upside of 692.08%. Given Mind Medicine (MindMed)’s higher possible upside, analysts clearly believe Mind Medicine (MindMed) is more favorable than Exactus.


Mind Medicine (MindMed) beats Exactus on 6 of the 9 factors compared between the two stocks.

Exactus Company Profile (Get Rating)

Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.

Mind Medicine (MindMed) Company Profile (Get Rating)

Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.

Receive News & Ratings for Exactus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactus and related companies with MarketBeat.com's FREE daily email newsletter.